Indie Asset Partners’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,104
Closed -$480K 77
2025
Q1
$480K Sell
1,104
-191
-15% -$76.7K 0.42% 40
2024
Q4
$478K Sell
1,295
-2
-0.2% -$837 0.38% 47
2024
Q3
$674K Sell
1,297
-4
-0.3% -$2.14K 0.51% 33
2024
Q2
$705K Sell
1,301
-137
-10% -$72.4K 0.56% 28
2024
Q1
$746K Sell
1,438
-75
-5% -$37.3K 0.66% 24
2023
Q4
$714K Sell
1,513
-95
-6% -$43.9K 0.64% 22
2023
Q3
$700K Hold
1,608
0.71% 20
2023
Q2
$714K Hold
1,608
0.78% 19
2023
Q1
$739K Sell
1,608
-66
-4% -$31.4K 0.86% 19
2022
Q4
$859K Sell
1,674
-57
-3% -$28.9K 0.94% 15
2022
Q3
$786K Sell
1,731
-10
-0.6% -$4.79K 0.81% 17
2022
Q2
$840K Sell
1,741
-12
-0.7% -$5.94K 0.74% 19
2022
Q1
$861K Sell
1,753
-119
-6% -$54.4K 0.65% 23
2021
Q4
$868K Sell
1,872
-109
-6% -$45.9K 0.63% 27
2021
Q3
$739K Sell
1,981
-1
-0.1% -$380 0.6% 31
2021
Q2
$757K Buy
1,982
+83
+4% +$31.7K 0.61% 30
2021
Q1
$682K Hold
1,899
0.78% 30
2020
Q4
$610K Sell
1,899
-27
-1% -$8.29K 0.71% 33
2020
Q3
$517K Hold
1,926
0.65% 40
2020
Q2
$537K Hold
1,926
0.67% 40
2020
Q1
$437K Buy
1,926
+35
+2% +$9.54K 0.55% 42
2019
Q4
$571K Buy
+1,891
New +$520K 0.61% 36

Other funds holding ELV

Indie Asset Partners's ELV Position: Q2 2025 in Review

Indie Asset Partners sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 1,104 shares — an estimated $480K sold.

Indie Asset Partners first reported a position in ELV in Q4 2019 and held it in 22 quarters. The position peaked at $868K in Q4 2021. 1,589 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

  • Indie Asset Partners reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
  • Indie Asset Partners sold 1,104 Elevance Health shares in Q2 2025, an estimated $480K.
  • Indie Asset Partners first reported a position in Elevance Health in Q4 2019 and held it in 22 quarters.
  • Indie Asset Partners's Elevance Health position peaked at $868K in Q4 2021.
  • 1,589 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on Indie Asset Partners's 13F filing for Q2 2025, filed 12 Aug 2025.